This is not the most recent version of the article. View current version (7 OCT 2009)

Intervention Protocol

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

  1. Mariacristina Parravano1,*,
  2. Francesca Menchini2

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 8 JUL 2009

DOI: 10.1002/14651858.CD007419

Database Title

Additional Information

How to Cite

Parravano M, Menchini F. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD007419. DOI: 10.1002/14651858.CD007419.

Author Information

  1. 1

    Fondazione G.B. Bietti per lo studio e la ricerca in Oftalmolologia-IRCCS, Ophthalmology, Rome, Italy

  2. 2

    University of Udine, Azienda Ospedaliero-universitaria di Udine, Department of Ophthalmology, Udine, Italy

*Mariacristina Parravano, Ophthalmology, Fondazione G.B. Bietti per lo studio e la ricerca in Oftalmolologia-IRCCS, Via Livenza n 3, Rome, 00198, Italy. criparra@tin.it.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 8 JUL 2009

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (07 Oct 2009)

View Full Article (HTML) Full (149K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Full (149K)